<p>Genome sequencing (GS) often reveals non-coding variants of uncertain significance, especially those predicted to affect pre-mRNA splicing. We present an integrative workflow combining splice prediction, a minigene assay and long-read RNA sequencing to assess their functional impact. Applied to a <i>de novo</i> heterozygous 17-bp intronic deletion in <i>FOXP1</i> from a child with a neurodevelopmental disorder, this approach showed impaired exon recognition and multiple aberrant transcript isoforms, supporting a loss-of-function mechanism consistent with <i>FOXP1</i> haploinsufficiency. Our results illustrate how experimental and isoform-resolved transcriptomic analyses can refine the interpretation of non-coding splice-altering variants detected by GS in clinical genomics.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Resolving non‑coding splice‑altering variants using an integrative genomic and transcriptomic workflow: application to FOXP1

  • Pauline Planté-Bordeneuve,
  • Anne-Sophie Jourdain,
  • Caroline Thuillier,
  • Aurélien Caux,
  • Marine Tessarech,
  • Jean-Pascal Meneboo,
  • Emilie Ait-Yahya,
  • Sara Costantini,
  • Perrine Brunelle,
  • Thomas Smol

摘要

Genome sequencing (GS) often reveals non-coding variants of uncertain significance, especially those predicted to affect pre-mRNA splicing. We present an integrative workflow combining splice prediction, a minigene assay and long-read RNA sequencing to assess their functional impact. Applied to a de novo heterozygous 17-bp intronic deletion in FOXP1 from a child with a neurodevelopmental disorder, this approach showed impaired exon recognition and multiple aberrant transcript isoforms, supporting a loss-of-function mechanism consistent with FOXP1 haploinsufficiency. Our results illustrate how experimental and isoform-resolved transcriptomic analyses can refine the interpretation of non-coding splice-altering variants detected by GS in clinical genomics.